Universitätsklinikum Heidelberg

SOP – Inappetenz und Kachexie (2024) Eschbach C, Villalobos M, Wolf C, Thomas M Journal article Schwangerschaft und Mutterschutz in der Kardiologie und in der Kinder- und Jugendkardiologie (2024) Güder G, Boer J, Busch S, Gaede L, Graf T, Herberg U, Kretschmer A, et al. Journal article Revaskularisation beim diabetischen Fußsyndrom? Wann und wie? (2024) Rother U, Görtz H, Uhl C, Stavroulakis K, Marchiori E, Classen S, Neufang A, et al. Journal article, Review article COVID-19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland (2024) Ulrich S, Balmer C, Becker K, Bruhs J, Danne F, Debus V, Dewein L, et al. Journal article The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects (2024) Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, Bergwelt-Baildon Mv, Subklewe M, et al. Journal article Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry (2024) Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, et al. Journal article, Original article A comparative analysis of the cytocompatibility, protein adsorption, osteogenic and angiogenic properties of the 45S5- and S53P4-bioactive glass compositions (2024) Westhauser F, Arango Ospina M, Hupa L, Renkawitz T, Boccaccini AR, Kunisch E Journal article Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study (2024) Beer BN, Kellner C, Goßling A, Sundermeyer J, Besch L, Dettling A, Kirchhof P, et al. Journal article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL (2024) Stelljes M, Raffel S, Alakel N, Wäsch R, Kondakci M, Scholl S, Rank A, et al. Journal article